Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly

por Marques, Nelma Veronica, Wildemberg, Luiz Eduardo Armondi, Gadelha, Monica R
Publicado 2023

Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience

por Gadelha, Mônica, Marques, Nelma Verônica, Fialho, Christhiane, Scaf, Cristiane, Lamback, Elisa, Antunes, Ximene, Santos, Erica, Magalhães, Jaqueline, Wildemberg, Luiz Eduardo
Publicado 2023

ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

por Vieria Neto, Leonardo, Wildemberg, Luiz Eduardo, Colli, Leandro Machado, Kasuki, Leandro, Marques, Nelma Veronica, Moraes, Aline Barbosa, Gasparetto, Emerson L., Takiya, Christina Maeda, Castro, Margaret, Gadelha, Mônica Roberto
Publicado 2013

Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

por Vieira Neto, Leonardo, Wildemberg, Luiz Eduardo, Colli, Leandro Machado, Kasuki, Leandro, Marques, Nelma Veronica, Moraes, Aline Barbosa, Gasparetto, Emerson L., Takiya, Christina Maeda, Castro, Margaret, Gadelha, Mônica Roberto
Publicado 2013